Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMX-30063 in ABSSSI
NCT01211470Phase 2Completed
- Sponsor
- PolyMedix, Inc.
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 3
01
Overview
A Phase 2 trial of brilacidin in acute bacterial skin and skin structure infection (ABSSSI), sponsored by PolyMedix, Inc.. Started Oct 2010; status: completed.
02
Drugs
brilacidin
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT01211470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211470.